Stay updated on Denosumab & Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Denosumab & Pembrolizumab in RCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference3%
- Check23 days agoChange DetectedUpdated core term from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and bumped revision from v3.0.2 to v3.1.0, indicating terminology refinement and a new version.SummaryDifference0.2%
- Check37 days agoChange DetectedRevision updated to v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as specific medical terms related to clear cell renal carcinoma and various antibodies. Notably, previous terms related to antineoplastic agents and certain location details have been removed.SummaryDifference4%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Denosumab & Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.